First Patient Receives Treatment in Retinitis Pigmentosa Clinical Trial

According to a story from BioPortfolio, the biopharmaceutical company GenSight Biologics recently announced that the first patient has received treatment in a Phase I/II clinical trial testing the company's experimental…

Continue Reading First Patient Receives Treatment in Retinitis Pigmentosa Clinical Trial
A New Startup is Hoping to Use Marijuana to Treat Inflammatory Diseases
herbalhemp / Pixabay

A New Startup is Hoping to Use Marijuana to Treat Inflammatory Diseases

According to a story from Business Insider, two researchers from Stanford University, Lawrence Steinman and Jonathan Rothbard, have decided to start a new company called Katexco Pharmaceuticals. This startup will…

Continue Reading A New Startup is Hoping to Use Marijuana to Treat Inflammatory Diseases
RAREfest’s Short Film Competition: Exploring Rare Diseases Through Film
Source: pixabay.com

RAREfest’s Short Film Competition: Exploring Rare Diseases Through Film

RAREfest, an event organised by the Cambridge Rare Disease Network (CRDN), will bring together patients, scientists, researchers, clinicians, support groups, businesses, and the public, to engage and educate people about…

Continue Reading RAREfest’s Short Film Competition: Exploring Rare Diseases Through Film
Experimental Treatment for GLUT1 Deficiency Syndrome Falters in Clinical Trial
stevepb / Pixabay

Experimental Treatment for GLUT1 Deficiency Syndrome Falters in Clinical Trial

According to a story from Biospace, the biopharmaceutical company Ultragenyx Pharmaceutical Inc. recently reported that its experimental product UX007 failed to achieve its primary endpoint in a recent clinical trial.…

Continue Reading Experimental Treatment for GLUT1 Deficiency Syndrome Falters in Clinical Trial
Close Menu